Hematología y Hemoterapia

Resultados: 408
Tipo Título / Nombre Autor(es) Año
CD8+ NKs as a potential biomarker of complete response and survival with lenalidomide plus R-GDP in the R2-GDPGOTEL trial in recurrent/ refractory diffuse large B cell lymphoma Hontecillas-Prieto L, García-Domínguez DJ, Palazón-Carrión N, Martín García-Sancho A..., Carnicero González F 2024
Association of laboratory test results with the bleeding history in patients with inherited platelet function disorders (the Bleeding Assesment Tool - LABoratory tests substudy): communication from the Platelet Physiology ISTH-SSC Gresele P, Falcinelli E, Bury L, Alessi MC, Guglielmini G..., Bermejo N, et al 2024
Feasibility and outcomes after dose reduction of immunochemotherapy in young adults with Burkitt lymphoma and leukemia: results of the BURKIMAB14 trial Ribera JM, Morgades M, Garcia-Calduch O, Sirvent M, Buendia B..., Bergua JM, et al 2024
Outcomes after intensive chemotherapy for secondary and myeloidrelated changes acute myeloid leukemia patients aged 60 to 75 years old: a retrospective analysis from the PETHEMA registry Martínez-Cuadrón D, Megías-Vericat JE, Gil C, Bernal T, Tormo M..., Bergua J, et al 2024
Clinical Features and Treatment in Patients Diagnosed with Blastic Plasmacytoid Dendritic Cell Neoplasm: Interim Analysis from the Pethema Epidemiologic Registry (EPI-BLAS study) Navarro Vicente I, Lloret Madrid P, Solana Altabella A..., Bergua Burgues JM 2023
LOTIS-5, an ongoing phase 3 randomized study of Loncastuximab Tesirine with Rituximab (Lonca-r) versus immunochemotherapy in patients with R/R DLBCL Carlo-Stella C, Kwiatek M, Chung M, Móciková H, Bergua-Burgues JM, Gao S, et al 2023
Incidence, risk factors and outcomes od second neoplasm in patients with acute promyelocytic leukemia: the PETHEMA -PALG experience Sobas M, Knopinska-Posluszny W, Pi?tkowska-Jakubas B..., Bergua Burgues JM 2023
AML-443 Clonal Evolution Analysis Using Next Generation Sequencing (NGS) Panel in a Cohort of 3,025 Patients With Acute Myeloid Leukemia (AML) Colmenares R, Sargas C..., Bergua Burgues JM 2023
FLT3-ITP mutation characterization with classical PCR methodology versus capture and amplicon based NGS platforms: a PETHEMA NGS-AML project Bilbao C, Stuckey R..., Bergua Burgues JM 2023
Safety and efficacy of LP-108 as monotherapy and combined with azacitidine in patients with relapsed/refractory myelodysplastic syndromes, chronic myelomonocytic leukemia, or acute myeloid leukemia Koenig K, Bergua Burgues JM, Montesinos P..., Curran E 2023